NIH News Release
NIH begins testing Ebola treatment in early-stage trial
Scientists developed monoclonal antibody from Ebola survivor.

Annual Report to the Nation: overall cancer mortality continues to decline, prostate cancer mortality has stabilized
Annual effort from NCI, CDC, the American Cancer Society, and the North American Association of Central Cancer Registries.

Women with pregnancy-related diabetes may be at risk for chronic kidney disease
Gestational diabetes occurs only in pregnancy and results when the level of blood sugar is too high.

NIH-funded researchers identify target for chikungunya treatment
Chikungunya is transmitted to humans by the bite of an infected mosquito.

Age-related racial disparity in suicide rates among U.S. youth
NIH-funded study suggests need for more research into contributing factors; targeted interventions for children.

Experimental MERS treatments enter clinical trial
NIH-sponsored trial to test two human monoclonal antibodies.

Method to identify undetected drug suicides wins top NIDA Addiction Science Award
A chip to monitor mouse movements and new rules for identifying natural compounds for research take second and third place.

NIH statement on HIV Vaccine Awareness Day - May 18, 2018
HIV remains a burden to individuals and communities in the United States and abroad.

Microglia are key defenders against prion diseases
Prion diseases are slow degenerative brain diseases that occur in people and various other mammals.

International study suggests combination therapy may prevent stroke in certain people
NIH-funded trial finds lower rate of secondary stroke but small risk of bleeding.

Feed Fetched by RSS Dog.